The project “International Expansion of Sensor Medica in the North American Market – WHX Miami 2025” has been carried out with the co-financing of the European Union through the European Regional Development Fund (ERDF), under the Lazio Regional Program ERDF 2021-2027, in accordance with the publicity obligations set out in Articles 49, 50 and Annex IX of Regulation (EU) 2021/1060 – CPR.

 

Sensor Medica will take part in the WHX Miami (formerly FIME Miami), one of the most prestigious and influential healthcare trade shows in the Americas, taking place in Miami from June 11 to 13, 2025.

 

The goal of the project is to strengthen Sensor Medica’s presence in the North American market by expanding relationships with distributors, clinics, and hospitals, while promoting cutting-edge technologies for posture diagnostics and movement analysis, such as Freemed and Spine3D.

 

Thanks to the ERDF contribution, it has been possible to:

•Set up a customized exhibition booth aligned with the brand identity and expectations of the U.S. audience, ensuring a strong communication impact.

•Cover participation costs, including logistics, transport, and technical support during the event.

•Translate and adapt promotional and technical materials to the language and regulatory context of the U.S. market.

•Promote Sensor Medica’s technologies in a top-level international setting, facilitating connections with qualified healthcare operators and global decision-makers.

 

Participation in WHX Miami 2025 marks a key milestone in Sensor Medica’s internationalization strategy, offering the opportunity to showcase the excellence of Made in Italy biomedical innovation to a highly selected audience and to open new commercial routes across North and South America.